Barbara A. Brown‐Elliott

Author

The University of Texas Health Science Center at Tyler ORCID

Also Known As

B A Brown-Elliott, B A Elliott, B Brown-Elliott, B Elliott, B. A. Brown-Elliott, B.A. Brown-Elliott, BARBARA A. BROWN-ELLIOTT, BARBARA A. ELLIOTT, BARBARA BROWN-ELLIOTT, Barbara A Brown-Elliott

227

Publications

20.6K

Citations

H-Index

135

Concepts

All Affiliations

The University of Texas Health Science Center at Tyler Mayo Clinic University of Minnesota, Duluth Centers for Disease Control and Prevention National Institutes of Health

About

Barbara A. Brown‐Elliott is an author at The University of Texas Health Science Center at Tyler specializing in medicine, clinical microbiology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	50	5K
2	Health Sciences	17	19	1.7K
3	Education	2	2	102
4	Engineering	2	2	156
5	Law	1	1	10

Barbara A. Brown‐Elliott

114

Publications

10.2K

Citations

H-Index

Page 1

	Year	Citations
Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes Gail L. Woods, Barbara A. Brown‐Elliott, Patricia S. Conville, Antimicrobial SusceptibilitySusceptibility TestingMicrobiologyMedicineClinical Microbiology	2011	1.2K
A Novel Gene, <i>erm</i> (41), Confers Inducible Macrolide Resistance to Clinical Isolates of <i>Mycobacterium abscessus</i> but Is Absent from <i>Mycobacterium chelonae</i> Kevin A. Nash, Barbara A. Brown‐Elliott, Richard J. Wallace Antimicrobial Agents and Chemotherapy	2009	636
Clinical and Molecular Analysis of Macrolide Resistance in <b> <i>Mycobacterium avium</i> </b> Complex Lung Disease David E. Griffith, Barbara A. Brown‐Elliott, Brett Langsjoen, American Journal of Respiratory and Critical Care Medicine	2006	350
Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease Richard J. Wallace, Barbara A. Brown‐Elliott, Steven G. McNulty, CHEST Journal Macrolide/azalide TherapyRespiratory InfectionTuberculosisInfectious Respiratory DiseasePulmonary Medicine	2014	337
Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease Kenneth N. Olivier, David E. Griffith, Gina Eagle, American Journal of Respiratory and Critical Care Medicine	2016	242
Clinical Experience with Linezolid for the Treatment of<i>Nocardia</i>Infection Edina Moylett, Susan E. Pacheco, Barbara A. Brown‐Elliott, Clinical Infectious Diseases Health SciencesAntibioticsNocardia SpeciesHealthcare-associated InfectionPharmacology	2003	231
Comparison of the In Vitro Activity of the Glycylcycline Tigecycline (Formerly GAR-936) with Those of Tetracycline, Minocycline, and Doxycycline against Isolates of Nontuberculous Mycobacteria Richard J. Wallace, Barbara A. Brown‐Elliott, Christopher J. Crist, Antimicrobial Agents and Chemotherapy	2002	225
Activities of Linezolid against Rapidly Growing Mycobacteria Richard J. Wallace, Barbara A. Brown‐Elliott, Shelby C. Ward, Antimicrobial Agents and Chemotherapy	2001	224
Cohort Study of Molecular Identification and Typing of <i>Mycobacterium abscessus, Mycobacterium massiliense</i> , and <i>Mycobacterium bolletii</i> Adrian M. Zelazny, Jeremy M. Root, Yvonne R. Shea, Journal of Clinical Microbiology	2009	220
Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii and designation of Mycobacterium abscessus subsp. massiliense comb. nov. Enrico Tortoli, Thomas A. Kohl, Barbara A. Brown‐Elliott, INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY Pathogenic MicrobiologyGeneticsBacteriologyPathologyDrug Resistance	2016	220

Page 1